Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
gptkb:danicopan
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Achillion_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
ACH-4471
|
| gptkbp:indication |
gptkb:paroxysmal_nocturnal_hemoglobinuria
|
| gptkbp:intendedUse |
treatment of complement-mediated diseases
|
| gptkbp:mechanismOfAction |
factor D inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
complement factor D
|
| gptkbp:bfsParent |
gptkb:Achillion_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|